TY  - JOUR

T1  - A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function

JO  - Cancer Chemotherapy and Pharmacology

PY  - 2015/01/01

AU  - Sharma S

AU  - Witteveen PO

AU  - Lolkema MP

AU  - Hess D

AU  - Gelderblom H

AU  - Hussain SA

AU  - Porro MG

AU  - Waldron E

AU  - Valera S-Z

AU  - Mu S

ED  - 

DO  - DOI: 10.1007/s00280-014-2612-8

PB  - Springer Science and Business Media LLC

VL  - 75

IS  - 1

SP  - 87

EP  - 95

Y2  - 2024/12/22

ER  -